SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-076871
Filing Date
2011-03-25
Accepted
2011-03-24 21:17:37
Documents
9
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1334504
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANT dex231.htm EX-23.1 1658
3 CERTIFICATION OF CEO dex311.htm EX-31.1 6544
4 CERTIFICATION OF CFO dex312.htm EX-31.2 6572
5 CERTIFICATION OF CEO dex321.htm EX-32.1 3484
6 CERTIFICATION OF CFO dex322.htm EX-32.2 3488
7 GRAPHIC g159254g14b37.jpg GRAPHIC 70651
8 GRAPHIC g159254g45j75.jpg GRAPHIC 56814
9 GRAPHIC g159254g54y57.jpg GRAPHIC 43631
  Complete submission text file 0001193125-11-076871.txt   1593424
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34828 | Film No.: 11710756
SIC: 2834 Pharmaceutical Preparations